Frequent CGM use results in greater glycemic benefits for adults with type 2 diabetes

Adults with type 2 diabetes who used a continuous glucose monitor and wore their sensor for more than 270 days in 1 year had greater HbA1c improvements than adults who did not use a CGM, researchers reported. In a retrospective cross-sectional analysis of Optum Market Clarity data published in JAMA Network Open, researchers observed that improvements in HbA1c at 1 year varied based on how often a